J9177 – Injection, enfortumab vedotin-ejfv, 0.25 mg
HCPCS Level II code · J codes: Drugs Administered Other Than Oral Method
HCPCS codeJ9177
- Long description
- Injection, enfortumab vedotin-ejfv, 0.25 mg
- Short description
- Inj enfort vedo-ejfv 0.25mg
- Pricing indicator
51Drugs- Medicare coverage
CCarrier judgment – coverage decided by the Medicare contractor- BETOS category
O1EOther drugs- ASC
- Approved for ambulatory surgical centers
- Added
- July 1, 2020
- Last change
- July 1, 2020 – No change
Frequently asked questions
What is HCPCS code J9177?
J9177 is a HCPCS Level II code for injection, enfortumab vedotin-ejfv, 0.25 mg.
Does Medicare cover J9177?
The HCPCS file lists coverage code C: Carrier judgment – coverage decided by the Medicare contractor. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby J codes
- J9161 – Injection, denileukin diftitox-cxdl, 1 mcg
- J9165 – Injection, diethylstilbestrol diphosphate, 250 mg
- J9171 – Injection, docetaxel, 1 mg
- J9172 – Injection, docetaxel (docivyx), 1 mg
- J9173 – Injection, durvalumab, 10 mg
- J9174 – Injection, docetaxel (beizray), 1 mg
- J9175 – Injection, elliotts' b solution, 1 ml
- J9176 – Injection, elotuzumab, 1 mg
- J9178 – Injection, epirubicin hcl, 2 mg
- J9179 – Injection, eribulin mesylate, 0.1 mg
- J9181 – Injection, etoposide, 10 mg
- J9183 – Gemcitabine intravesical system, 225 mg
- J9184 – Injection, gemcitabine hydrochloride (avyxa), 200 mg
- J9185 – Injection, fludarabine phosphate, 50 mg
- J9186 – Injection, etoposide (avyxa), 1 mg
- J9187 – Injection, etoposide, 1 mg
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.